BioCis Pharma Oy
Records under this name other than patents BioCis Pharma Oy holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to BioCis Pharma Oy
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,673,280 | Pharmaceutical composition for intracellar acidification with cis-urocanic acid Lapsed on the fee record Ended Mar 18, 2022 · From the USPTO record | Lapsed on the fee record | Ended Mar 18, 2022 | From the USPTO record |
| US 8,673,281 | Pharmaceutical composition for intracellular acidification with cis-urocanic acid Lapsed on the fee record Ended Mar 18, 2022 · From the USPTO record | Lapsed on the fee record | Ended Mar 18, 2022 | From the USPTO record |
| US 8,338,475 | Anti-proliferative pharmaceutical composition Lapsed on the fee record Ended Dec 25, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 25, 2020 | From the USPTO record |
| US 8,313,738 | Pharmaceutical composition for intracellular acidification with cis-urocanic acid Lapsed on the fee record Ended Nov 20, 2020 · From the USPTO record | Lapsed on the fee record | Ended Nov 20, 2020 | From the USPTO record |
| US 5,455,036 | Method of using cis-urocaninic acid for topically treating psoriasis Term ended Term ended no later than Oct 3, 2015 · Low confidence | Term ended | Term ended no later than Oct 3, 2015 | Low confidence |
| US 5,494,676 | Dermatological compositions containing CIS-urocaninic acid Term ended Term ended no later than Feb 27, 2016 · Low confidence | Term ended | Term ended no later than Feb 27, 2016 | Low confidence |